Sign in

CIK 0000885590 · Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
operating
Phone
514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. S-8 Other Securities Offered to Employees in Benefit Plans
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Grant or award SVP, Controller & CAO acquired 49,254 shares (grant or award)
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 4 Grant or award EVP, US Pharma acquired 144,352 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 986 shares (grant or award)
  9. 4 Grant or award Director acquired 4,752 shares (grant or award)
  10. 4 Grant or award Director acquired 8,967 shares (grant or award)
  11. 4 Shares withheld for taxes SVP, Controller & CAO gave up 1,930 shares (to pay taxes)
  12. 4/A Grant or award SVP, Controller & CAO acquired 39,126 shares (grant or award)
  13. 4/A Grant or award Chief Executive Officer acquired 519,328 shares (grant or award)
  14. 4/A Insider Changes in Ownership
  15. 4 Grant or award Director acquired 35,360 shares (grant or award)
  16. 4 Grant or award Director acquired 35,360 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Director acquired 35,360 shares (grant or award)
  19. 4 Grant or award Director acquired 35,360 shares (grant or award)
  20. 4 Grant or award Director acquired 35,360 shares (grant or award)

Page 10 of 121 · 2,419 filings